Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson.
Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 22% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $626,665 and 3, calls, for a total amount of $170,474.
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $150.0 and $160.0 for Johnson & Johnson, spanning the last three months.
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale trades within a strike price range from $150.0 to $160.0 in the last 30 days.
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | PUT | TRADE | NEUTRAL | 10/18/24 | $2.25 | $2.21 | $2.23 | $155.00 | $200.7K | 1.5K | 1.8K |
JNJ | PUT | TRADE | BEARISH | 10/18/24 | $2.22 | $2.17 | $2.23 | $155.00 | $200.7K | 1.5K | 933 |
JNJ | PUT | SWEEP | BULLISH | 11/15/24 | $3.25 | $3.15 | $3.15 | $155.00 | $126.0K | 148 | 448 |
JNJ | CALL | SWEEP | NEUTRAL | 09/20/24 | $2.03 | $2.02 | $2.03 | $160.00 | $75.9K | 12.6K | 1.7K |
JNJ | CALL | SWEEP | BULLISH | 09/20/24 | $2.12 | $2.12 | $2.12 | $160.00 | $69.3K | 12.6K | 902 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $188.75.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.
Posted In: JNJ